UK Clinical Research Network : Portfolio Database User Guide  
Welcome to the UK Clinical Research Network Study Portfolio  


NB: The information displayed below does not replace the protocol. The latest protocol version should always be consulted before making clinical decisions.
Users' and carers' views of stratified medicine

Mental Health Service Users' and Carers' Views of Stratified Medicine for Treatment Resistant Schizophrenia

Specialty
MentalHealth
Portfolio Eligibility
Automatically eligible
ISRCTN
EudraCT
MREC N° 13/NE/0103
UKCRN ID 14367
WHO ID
Research Summary
Study Type Observational
Design Type Qualitative
Disease(s) Schizophrenia
Phase N/A
Current Status Closed - follow-up complete
Closure Date 6/10/2013
Global Sample Size 24
Global Recruitment to Date
112%
Geographical Scope UK Multi-Centre
Lead Country England (also active in Scotland)
Main Inclusion Criteria
1. Identified as having treatment-resistant schizophrenia
2. Able to give informed consent
3. Sufficiently fluent in English to take part in a focus group
4. Aged between 18 and 60 years
Main Exclusion Criteria
1. Organic brain issues
2. Does not have capacity to give informed consent
3. Under 18 years or over 60 years
Chief Investigator(s)
Dr Diana Rose
Further details, please contact
Dr Constantina Papoulias

King's College London
Institute Of Psychiatry
16 De Crespigny Park
London
SE5 8AF
UNITED KINGDOM

Tel: 02078485147
konstantina.papoulia@kcl.ac.uk
Dr Diana Rose

King's College London
Institute Of Psychiatry
16 De Crespigny Park
London
SE5 8AF
UNITED KINGDOM

Tel: 0207 848 5066
diana.rose@kcl.ac.uk
Funder(s) Medical Research Council (MRC)
Sponsor(s) King's College London




public.ukcrn.org.uk/search
If you experience problems using the application, please click here.